Agency Information Collection Activities: Submission for OMB Review; Comment Request, 19744-19745 [2017-08588]

Download as PDF 19744 Federal Register / Vol. 82, No. 81 / Friday, April 28, 2017 / Notices Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: April 25, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: April 25, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–08626 Filed 4–27–17; 8:45 am] Center for Scientific Review; Notice of Closed Meeting [FR Doc. 2017–08627 Filed 4–27–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting asabaliauskas on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIGMS Initial Review GroupTraining and Workforce Development Subcommittee—C To review R25 Research Training Grant applications. Date: June 22–23, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: DoubleTree By Hilton Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Lee Warren Slice, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 1 Democracy Plaza, 6701 Democracy Blvd. Room 1068, Bethesda, MD 20892, 301–435– 0807, slicelw@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) VerDate Sep<11>2014 17:38 Apr 27, 2017 Jkt 241001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorder and Stroke Special Emphasis Panel; P30 and R24 Review. Date: May 23, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Capital View, 2850 South Potomac Avenue, Arlington, VA 22202. Contact Person: Jimok Kim, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892–9529, (301) 496–9223, JimokKim@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: April 25, 2017. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–08631 Filed 4–27–17; 8:45 am] BILLING CODE 4140–01–P PO 00000 National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR17–033: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment. Date: May 24, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Alexei Kondratyev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301–435– 1785, kondratyevad@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 25, 2017. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2017–08624 Filed 4–27–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\28APN1.SGM 28APN1 19745 Federal Register / Vol. 82, No. 81 / Friday, April 28, 2017 / Notices OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Project: Mandatory Guidelines for Federal Workplace Drug Testing Programs (OMB No. 0930–0158)— Revision SAMHSA will request OMB approval for the Federal Drug Testing Custody and Control Form (CCF) for federal agency and federally regulated drug testing programs which must comply with the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (82 FR 7920) dated January 23, 2017, and OMB approval for information provided by test facilities (laboratories and Instrumented Initial Test Facilities, IITFs) for the National Laboratory Certification Program (NLCP). The CCF is used by all federal agencies and employers regulated by the Department of Transportation (DOT) and the Nuclear Regulatory Commission (NRC) to document the collection and chain of custody of urine specimens at the collection site, for HHS-certified test facilities to report results, and for Medical Review Officers (MROs) to document and report a verified result. SAMHSA allows the use of the CCF as a paper or electronic form. The current OMB-approved CCF has a May 31, 2017 expiration date. SAMHSA has resubmitted the CCF with minor content revisions to the form for OMB approval. These revisions are: • Remove the checkbox, the letters ‘‘DOT’’, and hash line in front of Specify DOT Agency in Step 1: Completed by collector or employer Representative; Line D: Specify Testing Authority. • Addition of four new analytes (oxycodone, oxymorphone, hydrocodone, and hydromorphone) in Step 5A: Primary Specimen Report— Completed by Test Facility. • Removal of the analyte methylenedioxyethylamphetamine (MDEA) in Step 5A: Primary Specimen Report—Completed by Test Facility. Based upon information from federal agencies and from DOT concerning their Custody and Control Form: Donor ............................................................................ Collector ........................................................................ Laboratory ..................................................................... IITF ................................................................................ Medical Review Officer ................................................. NLCP Application Form: Laboratory ..................................................................... IITF ................................................................................ Sections B and C—NLCP Inspection Checklist: Laboratory ..................................................................... IITF ................................................................................ Recordkeeping: Laboratory ..................................................................... IITF ................................................................................ asabaliauskas on DSK3SPTVN1PROD with NOTICES Total ....................................................................... Written comments and recommendations concerning the proposed information collection should be sent by May 30, 2017 to the SAMHSA Desk Officer at the Office of Information and Regulatory Affairs, Office of Management and Budget (OMB). To ensure timely receipt of comments, and to avoid potential delays in OMB’s receipt and processing of mail sent through the U.S. Postal Service, commenters are encouraged to submit their comments to OMB via email to: OIRA_Submission@omb.eop.gov. Although commenters are encouraged to send their comments via email, commenters may also fax their comments to: 202–395–7285. VerDate Sep<11>2014 17:38 Apr 27, 2017 Jkt 241001 Responses per respondent Number of respondents Form/respondent regulated industries, the number of respondents has been reduced from a total of 6.1 million in 2013 to 5.4 million, which reduces the total burden hours by 188,766. Laboratories and IITFs seeking HHS certification under the NLCP must complete and submit the NLCP application form. The NLCP application form has not been revised compared to the previous form. Prior to an inspection, an HHScertified laboratory or IITF is required to submit specific information regarding its procedures. Collecting this information prior to an inspection allows the inspectors to thoroughly review and understand the testing procedures before arriving for the onsite inspection. The NLCP information checklist has not been revised compared to the previous form. The annual total burden estimates for the CCF, the NLCP application, the NLCP information checklist, and the NLCP recordkeeping requirements are shown in the following table. Total number of responses Burden per response (hours) Annual burden (hours) 5,400,000 5,400,000 5,400,000 0 5,400,000 1 1 1 0 1 5,400,000 5,400,000 5,400,000 0 5,400,000 0.08 0.07 0.05 0 0.05 450,000 360,000 270,000 0 270,000 1 0 1 0 1 0 3 0 3 0 30 0 1 0 30 0 1 0 30 0 30 0 1 0 30 0 250 0 7,500 0 5,400,061 ........................ 5,400,061 ........................ 1,357,533 Commenters may also mail them to: Office of Management and Budget, Office of Information and Regulatory Affairs, New Executive Office Building, Room 10102, Washington, DC 20503. DEPARTMENT OF HOMELAND SECURITY Summer King, Statistician. [Docket ID FEMA–2008–0010] [FR Doc. 2017–08588 Filed 4–27–17; 8:45 am] Federal Emergency Management Agency Board of Visitors for the National Fire Academy BILLING CODE 4162–20–P PO 00000 Federal Emergency Management Agency, DHS. ACTION: Committee Management; Notice of Open Federal Advisory Committee Meeting. AGENCY: The Board of Visitors for the National Fire Academy (Board) will SUMMARY: Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\28APN1.SGM 28APN1

Agencies

[Federal Register Volume 82, Number 81 (Friday, April 28, 2017)]
[Notices]
[Pages 19744-19745]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08588]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under

[[Page 19745]]

OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. 
Chapter 35). To request a copy of these documents, call the SAMHSA 
Reports Clearance Officer on (240) 276-1243.

Project: Mandatory Guidelines for Federal Workplace Drug Testing 
Programs (OMB No. 0930-0158)--Revision

    SAMHSA will request OMB approval for the Federal Drug Testing 
Custody and Control Form (CCF) for federal agency and federally 
regulated drug testing programs which must comply with the HHS 
Mandatory Guidelines for Federal Workplace Drug Testing Programs using 
Urine (82 FR 7920) dated January 23, 2017, and OMB approval for 
information provided by test facilities (laboratories and Instrumented 
Initial Test Facilities, IITFs) for the National Laboratory 
Certification Program (NLCP).
    The CCF is used by all federal agencies and employers regulated by 
the Department of Transportation (DOT) and the Nuclear Regulatory 
Commission (NRC) to document the collection and chain of custody of 
urine specimens at the collection site, for HHS-certified test 
facilities to report results, and for Medical Review Officers (MROs) to 
document and report a verified result. SAMHSA allows the use of the CCF 
as a paper or electronic form.
    The current OMB-approved CCF has a May 31, 2017 expiration date. 
SAMHSA has resubmitted the CCF with minor content revisions to the form 
for OMB approval. These revisions are:
     Remove the checkbox, the letters ``DOT'', and hash line in 
front of Specify DOT Agency in Step 1: Completed by collector or 
employer Representative; Line D: Specify Testing Authority.
     Addition of four new analytes (oxycodone, oxymorphone, 
hydrocodone, and hydromorphone) in Step 5A: Primary Specimen Report--
Completed by Test Facility.
     Removal of the analyte methylenedioxyethylamphetamine 
(MDEA) in Step 5A: Primary Specimen Report--Completed by Test Facility.
    Based upon information from federal agencies and from DOT 
concerning their regulated industries, the number of respondents has 
been reduced from a total of 6.1 million in 2013 to 5.4 million, which 
reduces the total burden hours by 188,766.
    Laboratories and IITFs seeking HHS certification under the NLCP 
must complete and submit the NLCP application form. The NLCP 
application form has not been revised compared to the previous form.
    Prior to an inspection, an HHS-certified laboratory or IITF is 
required to submit specific information regarding its procedures. 
Collecting this information prior to an inspection allows the 
inspectors to thoroughly review and understand the testing procedures 
before arriving for the onsite inspection. The NLCP information 
checklist has not been revised compared to the previous form.
    The annual total burden estimates for the CCF, the NLCP 
application, the NLCP information checklist, and the NLCP recordkeeping 
requirements are shown in the following table.

----------------------------------------------------------------------------------------------------------------
                                                                                    Burden  per
         Form/respondent             Number of     Responses per   Total  number     response     Annual  burden
                                    respondents     respondent     of  responses      (hours)         (hours)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form:
    Donor.......................       5,400,000               1       5,400,000            0.08         450,000
    Collector...................       5,400,000               1       5,400,000            0.07         360,000
    Laboratory..................       5,400,000               1       5,400,000            0.05         270,000
    IITF........................               0               0               0               0               0
    Medical Review Officer......       5,400,000               1       5,400,000            0.05         270,000
NLCP Application Form:
    Laboratory..................               1               1               1               3               3
    IITF........................               0               0               0               0               0
Sections B and C--NLCP
 Inspection Checklist:
    Laboratory..................              30               1              30               1              30
    IITF........................               0               0               0               0               0
Recordkeeping:
    Laboratory..................              30               1              30             250           7,500
    IITF........................               0               0               0               0               0
                                 -------------------------------------------------------------------------------
        Total...................       5,400,061  ..............       5,400,061  ..............       1,357,533
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent by May 30, 2017 to the SAMHSA 
Desk Officer at the Office of Information and Regulatory Affairs, 
Office of Management and Budget (OMB). To ensure timely receipt of 
comments, and to avoid potential delays in OMB's receipt and processing 
of mail sent through the U.S. Postal Service, commenters are encouraged 
to submit their comments to OMB via email to: 
OIRA_Submission@omb.eop.gov. Although commenters are encouraged to send 
their comments via email, commenters may also fax their comments to: 
202-395-7285. Commenters may also mail them to: Office of Management 
and Budget, Office of Information and Regulatory Affairs, New Executive 
Office Building, Room 10102, Washington, DC 20503.

Summer King,
Statistician.
[FR Doc. 2017-08588 Filed 4-27-17; 8:45 am]
 BILLING CODE 4162-20-P